DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Doody RS, Thomas RG, Farlow M et al.
Phase 3 trials of solane-zumab for mild-to-moderate Alzheimer’s disease.
N Engl J Med 2014;
370: 311-321
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.